| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 499 | 2022 |
| Characterization of H7N9 influenza A viruses isolated from humans T Watanabe, M Kiso, S Fukuyama, N Nakajima, M Imai, S Yamada, ... Nature 501 (7468), 551-555, 2013 | 460 | 2013 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 220 | 2022 |
| Efficacy of antiviral agents against omicron subvariants BQ. 1.1 and XBB M Imai, M Ito, M Kiso, S Yamayoshi, R Uraki, S Fukushi, S Watanabe, ... New England Journal of Medicine 388 (1), 89-91, 2023 | 205 | 2023 |
| Zika virus productively infects primary human placenta-specific macrophages KA Jurado, MK Simoni, Z Tang, R Uraki, J Hwang, S Householder, M Wu, ... JCI insight 1 (13), 2016 | 181 | 2016 |
| TAM receptors are not required for Zika virus infection in mice AK Hastings, LJ Yockey, BW Jagger, J Hwang, R Uraki, HF Gaitsch, ... Cell reports 19 (3), 558-568, 2017 | 155 | 2017 |
| Zika virus causes testicular atrophy R Uraki, J Hwang, KA Jurado, S Householder, LJ Yockey, AK Hastings, ... Science advances 3 (2), e1602899, 2017 | 152 | 2017 |
| Humoral immune evasion of the omicron subvariants BQ. 1.1 and XBB R Uraki, M Ito, Y Furusawa, S Yamayoshi, K Iwatsuki-Horimoto, E Adachi, ... The Lancet Infectious Diseases 23 (1), 30-32, 2023 | 125 | 2023 |
| Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses S Yamayoshi, S Yamada, S Fukuyama, S Murakami, D Zhao, R Uraki, ... Journal of virology 88 (6), 3127-3134, 2014 | 121 | 2014 |
| The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ... Research square, 2021 | 115 | 2021 |
| Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus M Kiso, R Takano, S Sakabe, H Katsura, K Shinya, R Uraki, S Watanabe, ... Scientific reports 3 (1), 1563, 2013 | 70 | 2013 |
| Characterization of SARS-CoV-2 Omicron BA. 4 and BA. 5 isolates in rodents R Uraki, PJ Halfmann, S Iida, S Yamayoshi, Y Furusawa, M Kiso, M Ito, ... Nature 612 (7940), 540-545, 2022 | 67 | 2022 |
| Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection Y Ano, A Sakudo, T Kimata, R Uraki, K Sugiura, T Onodera Neuroscience letters 469 (1), 39-43, 2010 | 60 | 2010 |
| Aedes aegypti NeSt1 Protein Enhances Zika Virus Pathogenesis by Activating Neutrophils AK Hastings, R Uraki, H Gaitsch, K Dhaliwal, S Stanley, H Sproch, ... Journal of Virology 93 (13), 10.1128/jvi. 00395-19, 2019 | 59 | 2019 |
| A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza A virus particle release S Yamayoshi, R Uraki, M Ito, M Kiso, S Nakatsu, A Yasuhara, K Oishi, ... EBioMedicine 17, 182-191, 2017 | 58 | 2017 |
| Antiviral and bivalent vaccine efficacy against an omicron XBB. 1.5 isolate R Uraki, M Ito, M Kiso, S Yamayoshi, K Iwatsuki-Horimoto, Y Furusawa, ... The Lancet Infectious Diseases 23 (4), 402-403, 2023 | 57 | 2023 |
| Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts S Yamayoshi, S Fukuyama, S Yamada, D Zhao, S Murakami, R Uraki, ... Scientific reports 5 (1), 8039, 2015 | 56 | 2015 |
| Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic … Y Muramoto, JE Shoemaker, MQ Le, Y Itoh, D Tamura, Y Sakai-Tagawa, ... Journal of virology 88 (16), 8981-8997, 2014 | 55 | 2014 |
| Fetal growth restriction caused by sexual transmission of Zika virus in mice R Uraki, KA Jurado, J Hwang, K Szigeti-Buck, TL Horvath, A Iwasaki, ... The Journal of infectious diseases 215 (11), 1720-1724, 2017 | 49 | 2017 |
| A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges R Uraki, M Kiso, K Iwatsuki-Horimoto, S Fukuyama, E Takashita, M Ozawa, ... Journal of Virology 87 (14), 7874-7881, 2013 | 49 | 2013 |
